$AJG

Arthur J. Gallagher (NYSE: AJG) director defers pay into 152.672-share award

Arthur J. Gallagher & Co. (AJG) director Christopher C. Miskel received a grant of 152,672 shares of common stock equivalents on September 1, 2026, as part of the company's Director Deferral Plan. This resulted from his prior election to defer his annual cash retainer into deferred share units. The grant reference price per share was $262.00, and his directly held position increased to 10,826.439 shares.

Original reporting
Published Sep 2, 2026, 9:55 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 3, 2026, 11:45 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
$AJG
Neutral
high confidence
Mentioned
$AJG
Relevance
4/10
AlphAI data visualization · based on stocktitan.net
Decision brief

The 30-second read

$AJGNeutralLow
01

Why it matters

The award is a routine compensation mechanism with no material effect on AJG's equity structure.

02

Market read

Limited relevance; the filing provides a minor insider update with no actionable trading implication.

03

What to watch

Potential future dilution when the deferred units settle, but impact is negligible.

Relevance 4/10Novelty 4/10Timing: September 1, 2026 filing date

Background

Form 4 filing discloses a director's deferred compensation converted to a small stock award.

Company-level read

Ticker impact

$AJGNeutralHigh confidence
Context

Director Christopher C. Miskel was granted 152.672 shares of AJG common stock under the Director Deferral Plan on September 1, 2026.

Expected impact

minimal, no immediate price movement expected

Evidence & confidence

Small size relative to market cap and no cash transaction; typical routine insider award.

Market effects

none

none

none

Counterpoint

The award is routine and does not signal any change in company strategy.

Key entities

  • Arthur J. Gallagher & Co.

    Insurance brokerage and risk management firm (NYSE: AJG).

  • Christopher C. Miskel

    Director of AJG receiving the deferred share award.

Related articles

$BROMedAI 8/10

Winners And Losers Of Q2: Baldwin Insurance Group (NASDAQ:BWIN) Vs The Rest Of The Insurance Brokers Stocks

Ryan Specialty beat estimates but fell 11.1% to $39.20. Brown & Brown (BRO) reported $1.68B revenue, up 30.4% YoY, missing estimates by 2.5%, and dropped 3.4% to $67.32. Arthur J. Gallagher (AJG) reported $4.00B revenue, up 24.3% YoY, missing estimates by 0.5%, and fell 3.3% to $248.05. Marsh (MRSH) reported $7.40B revenue, up 6.2% YoY, beating estimates by 1.8%, and dropped 1.2% to $179.91.

$AJGMed

Arthur J. Gallagher buys McMillan Insurance & Bonding

Arthur J. Gallagher acquired McMillan Insurance & Bonding, doing business as Innovise Business Consultants, based in Englewood, Colorado. The company offers commercial insurance and bonding services. Terms were not disclosed. Innovise's team will join Gallagher's Denver office. According to Seeking Alpha, the deal expands Gallagher's presence in the Western U.S.

$AJGMedAI 8/10

Arthur J. Gallagher & Co. Acquires Apollo Insurance Solutions Ltd.

Arthur J. Gallagher & Co. (NYSE:AJG) said it will acquire Vancouver-based Apollo Insurance Solutions Ltd., a Canadian digital insurance broker and MGA focused on tenant insurance. The deal terms were not disclosed. Apollo’s team will remain in Vancouver under Gallagher’s Canadian retail property/casualty leadership, aiming to expand Gallagher’s Canada capabilities.

$AJGMed

Gallagher posts revenue increase of 24% to $4bn for Q2'26

Insurance broking group Arthur J. Gallagher & Co. has reported total revenue before reimbursement of USD 3.955 billion for the second quarter of 2026, compared to USD 3.2 billion in Q2’25, as the combined brokerage and risk management segments delivered 24% total revenue growth, including organic growth of 6%.